Platelet-Derived Growth Factor Receptor Type α Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
05 04 2022
Historique:
pubmed: 30 3 2022
medline: 8 4 2022
entrez: 29 3 2022
Statut: ppublish

Résumé

Background Platelet-derived growth factor is a major regulator of the vascular remodeling associated with pulmonary arterial hypertension. We previously showed that protein widely 1 (PW1

Identifiants

pubmed: 35348002
doi: 10.1161/JAHA.121.023021
pmc: PMC9075467
doi:

Substances chimiques

Receptor, Platelet-Derived Growth Factor alpha EC 2.7.10.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e023021

Références

Arterioscler Thromb Vasc Biol. 2015 May;35(5):1236-45
pubmed: 25745058
Nature. 2016 Dec 8;540(7632):276-279
pubmed: 27894125
Proc Natl Acad Sci U S A. 2012 Jul 3;109(27):10879-84
pubmed: 22745168
Am J Pathol. 2017 Oct;187(10):2273-2287
pubmed: 28734947
Am J Respir Cell Mol Biol. 2011 Oct;45(4):804-8
pubmed: 21378262
Am J Respir Cell Mol Biol. 2012 Oct;47(4):517-27
pubmed: 22652199
Dev Biol. 1996 Aug 1;177(2):383-96
pubmed: 8806818
Sci Transl Med. 2015 Oct 7;7(308):308ra159
pubmed: 26446956
Glia. 2016 Jan;64(1):122-38
pubmed: 26345464
J Histochem Cytochem. 1997 Jun;45(6):883-93
pubmed: 9199674
Dev Biol. 2018 Oct 1;442(1):155-161
pubmed: 30026121
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):766-782
pubmed: 31969018
PLoS One. 2018 Dec 31;13(12):e0209786
pubmed: 30596712
Development. 2018 Apr 10;145(7):
pubmed: 29636361
Dev Cell. 2009 Feb;16(2):303-13
pubmed: 19217431
J Cell Biochem. 2019 Mar;120(3):4355-4365
pubmed: 30246400
J Heart Lung Transplant. 2015 Nov;34(11):1366-75
pubmed: 26210752
Pulm Circ. 2013 Jan;3(1):31-49
pubmed: 23662173
J Clin Invest. 2010 Jan;120(1):242-53
pubmed: 20038802
Stem Cells Int. 2015;2015:362753
pubmed: 26257789
J Invest Dermatol. 1996 Nov;107(5):770-7
pubmed: 8875964
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11470-5
pubmed: 21709251
J Clin Invest. 2009 Mar;119(3):512-23
pubmed: 19197140
Circulation. 2014 Apr 15;129(15):1586-97
pubmed: 24481949
Pulm Circ. 2011 Apr-Jun;1(2):259-68
pubmed: 22034611
Sci Rep. 2017 Nov 23;7(1):16192
pubmed: 29170419
Am J Respir Cell Mol Biol. 2016 Apr;54(4):532-45
pubmed: 26414960
J Clin Invest. 2005 Oct;115(10):2811-21
pubmed: 16200212
Genes Dev. 2015 Jun 1;29(11):1106-19
pubmed: 26019175
Am J Physiol Cell Physiol. 2014 Oct 15;307(8):C684-98
pubmed: 25122876
Elife. 2018 Sep 04;7:
pubmed: 30178747
Int J Biochem Cell Biol. 2007;39(2):379-91
pubmed: 17070723
Int J Mol Sci. 2019 Dec 23;21(1):
pubmed: 31877978
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545970
Am J Pathol. 1996 Aug;149(2):539-48
pubmed: 8701993
Eur Respir J. 1998 Mar;11(3):554-9
pubmed: 9596101
Circ Res. 2016 Mar 4;118(5):822-33
pubmed: 26838788
Int J Biochem Cell Biol. 2016 May;74:44-59
pubmed: 26905437
Cell Stem Cell. 2016 Dec 1;19(6):738-751
pubmed: 27746098
Oncotarget. 2017 May 2;8(18):29643-29656
pubmed: 28410244
Neuron. 1998 May;20(5):869-82
pubmed: 9620692
Am J Respir Crit Care Med. 2008 Jul 1;178(1):81-8
pubmed: 18420966
Am J Pathol. 2006 Feb;168(2):659-69
pubmed: 16436679
Respir Res. 2019 Jun 6;20(1):111
pubmed: 31170998
Dev Biol. 2016 Jan 15;409(2):429-41
pubmed: 26632490
Development. 2014 Feb;141(3):548-55
pubmed: 24449836
Am J Physiol Lung Cell Mol Physiol. 2015 Nov 1;309(9):L942-58
pubmed: 26320158
Genes Dev. 2008 May 15;22(10):1276-312
pubmed: 18483217

Auteurs

Julien Solinc (J)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

Jessica Raimbault-Machado (J)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

France Dierick (F)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
Lady Davis Institute for Medical Research, McGill University Montréal QC Canada.

Lamiaa El Bernoussi (L)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

Ly Tu (L)

Université Paris-Saclay, School of Medicine Le Kremlin-Bicêtre France.
INSERM, Hôpital Marie Lannelongue, UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies Le Plessis-Robinson France.

Raphaël Thuillet (R)

Université Paris-Saclay, School of Medicine Le Kremlin-Bicêtre France.
INSERM, Hôpital Marie Lannelongue, UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies Le Plessis-Robinson France.

Nathalie Mougenot (N)

Sorbonne Universités, INSERM, UMS2, Faculté de Médecine Pitié-Salpêtrière Paris France.

Bénédicte Hoareau-Coudert (B)

Sorbonne Université, INSERM, Plateforme CyPS, Faculté de Médecine Pitié-Salpêtrière Paris France.

Virginie Monceau (V)

IRSN, LRTOX Fontenay aux Roses France.

Catherine Pavoine (C)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

Fabrice Atassi (F)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

David Sassoon (D)

Université de Paris, INSERM, Paris Cardiovascular Research Center Paris France.

Giovanna Marazzi (G)

Université de Paris, INSERM, Paris Cardiovascular Research Center Paris France.

Richard P Harvey (RP)

Victor Chang Cardiac Research Institute Darlinghurst Australia.
St. Vincent's Clinical School and School of Biotechnology and Biomolecular Science UNSW Sydney Sydney Australia.

Peter Schofield (P)

St. Vincent's Clinical School and School of Biotechnology and Biomolecular Science UNSW Sydney Sydney Australia.
Immunology Division Garvan Institute of Medical Research Darlinghurst Australia.

Daniel Christ (D)

St. Vincent's Clinical School and School of Biotechnology and Biomolecular Science UNSW Sydney Sydney Australia.
Immunology Division Garvan Institute of Medical Research Darlinghurst Australia.

Marc Humbert (M)

Université Paris-Saclay, School of Medicine Le Kremlin-Bicêtre France.
INSERM, Hôpital Marie Lannelongue, UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies Le Plessis-Robinson France.
Department of Respiratory and Intensive Care Medicine Assistance Publique-Hôpitaux de Paris (AP-HP)Pulmonary Hypertension National Referral CenterHôpital Bicêtre Le Kremlin-Bicêtre France.

Christophe Guignabert (C)

Université Paris-Saclay, School of Medicine Le Kremlin-Bicêtre France.
INSERM, Hôpital Marie Lannelongue, UMR_S 999 «Pulmonary Hypertension: Pathophysiology and Novel Therapies Le Plessis-Robinson France.

Florent Soubrier (F)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

Sophie Nadaud (S)

Sorbonne Université, INSERM, UMR_S 1166, Faculté de Médecine Pitié-Salpêtrière Paris France.
ICAN Institute Paris France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH